Neuromodulation

In October 2024, the Norwegian Directorate of Health released the Norwegian Clinical Procedure Coding (NKPK) system for 2025. A total of 15 new codes were introduced concerning cardiovascular, interventional radiology, neuromodulation, pulmonary, surgical procedures, and spine fields.

In August 2024, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance concerning caval valve implantation for tricuspid regurgitation and phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury and for congenital central hypoventilation syndrome. Furthermore, two new clinical guidelines were published for diabetic retinopathy and adrenal insufficiency.

In August 2024, NICE prioritization board decisions were published regarding the following Med Tech-related topics: clinical guidelines on lower urinary tract symptoms in men (prioritized), NPi-200 for pupillary light reflex in critical care (not prioritized), Aquablation robotic therapy in benign prostatic hyperplasia (not prioritized), and tumor treating fields in glioblastoma (not prioritized).

In September 2024, the Canary Islands Healthcare Evaluation Service (SESCS) is working on several HTAs, including evaluations in neuromodulation, IVD, and some other fields.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in August 2024. Five recommendations were published concerning the registration of medical devices or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, peripheral vascular, neuromodulation, orthopedic, and spine devices.

In the second quarter of 2024, the Dutch Healthcare Institute (ZIN) published four coverage positions on proton therapy in testicular cancer, pulmonary artery pressure remote monitoring in chronic heart failure and neuromodulation in polyneuropathy with positive recommendation for coverage under basic insurance package, and on physiotherapy and exercise therapy in primary care settings for lower back pain, which was not recommended for coverage under the basic insurance package.

On May 27, 2024, the Danish Health Technology Council released two new publications: an evaluation of Optune® (Novocure) and a major analysis on the treatment of obstructive sleep apnea.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2024. Seven recommendations were published concerning the registration of medical devices or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern neurovascular, neuromodulation, endocrine, ophthalmology, and orthopedic devices, as well as medical aids.

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in April 2024. Eighteen recommendations were published concerning the registration of medical devices or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). Opinions concern cardiovascular, neurovascular, gastrointestinal, interventional radiology, nephrology and urology, neuromodulation, and orthopedic devices, as well as medical aids.

On April 3, 2024, NHS England published the 2024/25 Prescribed Specialised Services (PSS) Operational Tool. This Tool is used as a mechanism to identify whether healthcare activity belongs to specialized services using so-called identification rules. Forty-three new service lines were introduced in multiple areas, and eight service lines were amended.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 4588 of March 5, 2024, Tuscany Regional Healthcare published two new assessments and one re-assessment of medical devices in the cardiovascular, neuromodulation, and surgical procedures areas.

In March 2024, several method assessments were initiated as a part of a framework for the managed introduction of innovations "New Methods" for cardiovascular, endocrine, gastrointestinal, men’s health, neurology and neurosurgery, neuromodulation, obstetrics and gynecology, robotic surgery, and some other fields.